Regenerative medicine to be covered soon

Major nonlife insurance companies soon will start selling new products to insure cell-cultivating companies against errors in regenerative medicine.

The launch, expected as early as October, will be the first time that such products have been sold in Japan. The new products are expected to encourage patients and hospitals to make use of regenerative medicine, as they will help cell-culturing firms pay compensation if problems arise in cultivated cells during treatments and clinical tests.

Regenerative medicine is designed to restore the functions of tissue damaged by illness or injury through the transplantation of cultivated cells.